AERS spider: An online interactive tool to mine statistical associations in adverse event reporting system

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 8, 2014, Pages 795-801

  Grigoriev, Igor ^a   zu Castell, Wolfgang ^a   Tsvetkov, Philipp ^b   Antonov, Alexey V ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

AERS; Data mining; FDA; Pharmacoepidemiology; Pharmacovigilance

Indexed keywords

ACETYLSALICYLIC ACID; BONE DENSITY CONSERVATION AGENT; CALCIUM; GLIBENCLAMIDE; METFORMIN;

ACCESS TO INFORMATION; ADVERSE EVENT REPORTING SYSTEM; ANGINA PECTORIS; ARTICLE; BONE DENSITY; DATA BASE; DATA MINING; DRUG SAFETY; DRUG USE; FRACTURE; FRACTURE REDUCTION; HEART INFARCTION; HUMAN; LACTIC ACIDOSIS; ONLINE SYSTEM; OPEN REDUCTION; OSTEOPOROSIS; PATENT; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FACTUAL DATABASE; FOOD AND DRUG ADMINISTRATION; PHARMACOEPIDEMIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA MINING; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; ONLINE SYSTEMS; PHARMACOEPIDEMIOLOGY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84905052696     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3561     Document Type: Article

References (22)

1. US Food and Drug Administration. Adverse Event Reporting System FDA 2012.
2. Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N. Novel statistical tools for monitoring the safety of marketed drugs 1. Clin Pharmacol Ther 2007; 82(2): 157-166.
3. Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting 1. Pharmacoepidemiol Drug Saf 2009; 18(6): 427-436.
4. Harpaz R, Perez H, Chase HS, Rabadan R, Hripcsak G, Friedman C. Biclustering of adverse drug events in the FDA's spontaneous reporting system 1. Clin Pharmacol Ther 2011; 89(2): 243-250.
5. Hauben M, Madigan D, Patadia V, Sakaguchi M, van Puijenbroek E. Quantitative signal detection for vaccines 1. Hum Vaccin 2010; 6(8): 681.
6. Hochberg AM, Hauben M. Time-to-signal comparison for drug safety data-mining algorithms vs. traditional signaling criteria 4. Clin Pharmacol Ther 2009; 85(6): 600-606.
7. Moore N, Hall G, Sturkenboom M, Mann R, Lagnaoui R, Begaud B. Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole. Pharmacoepidemiol Drug Saf 2003; 12(4): 271-281.
8. Stephenson WP, Hauben M. Data mining for signals in spontaneous reporting databases: proceed with caution 1. Pharmacoepidemiol Drug Saf 2007; 16(4): 359-365.
9. Trifiro G, Pariente A, Coloma PM, et al. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? 5. Pharmacoepidemiol Drug Saf 2009; 18(12): 1176-1184.
10. Waller P, Beard K, Egberts T, et al. European commission consultation on pharmacovigilance 6. Pharmacoepidemiol Drug Saf 2008; 17(2): 108-9.
11. Wang HW, Hochberg AM, Pearson RK, Hauben M. An experimental investigation of masking in the US FDA adverse event reporting system database 1. Drug Saf 2010; 33(12): 1117-1133.
12. Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions 1. Sci Transl Med 2012; 4(125): 125ra31.
13. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10(6): 483-486.
14. Levine JG, Tonning JM, Szarfman A. Reply: The evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learned 4. Br J Clin Pharmacol 2006; 61(1): 105-113.
15. Pratt LA, Danese PN. More eyeballs on AERS 1. Nat Biotechnol 2009; 27(7): 601-2.
16. Anonymous. Making a difference. Nat Biotechnol 2009; 27(297).
17. Bohm R, Hocker J, Cascorbi I, Herdegen T. OpenVigil-free eyeballs on AERS pharmacovigilance data 1. Nat Biotechnol 2012; 30(2): 137-138.
18. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance 3. Expert Opin Drug Saf 2005; 4(5): 929-948.
19. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance 4. Br J Clin Pharmacol 2004; 57(2): 127-134.
20. Knox C, Law V, Jewison T, et al. DrugBank 3.0: a comprehensive resource for "omics" research on drugs 1. Nucleic Acids Res 2011; 39(Database issue): D1035-D1041.
21. Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist 2006; 11(10): 1121-1131.
22. Misbin RI. The phantom of lactic acidosis due to metformin in patients with diabetes 3. Diabetes Care 2004; 27(7): 1791-1803.